(To read more on the industrial market, click here.)
CAMBRIDGE, MA-A biopharmaceutical firm has inked a long-termexpansion lease for 23,199 sf of lab space at the Cambridge ScienceCenter. The agreement gives the company a total of a total of63,329 sf of lab and office space in the 245 First St. complex.
The expansion by CombinatoRx Inc. brings occupancy in thetwo-building, 130,512-sf property to 90%, Maryann Gilligan Suydam,senior vice president of Equity Office's Boston Region, tellsGlobeSt.com. "We continue to see the biotech industry strengthen.We're beginning to see signs of more internal growth by ourexisting customer base, and positive net absorption in this marketsegment."
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
*May exclude premium content
Already have an account?
Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
